Page last updated: 2024-08-23

fosinopril and atrial natriuretic factor

fosinopril has been researched along with atrial natriuretic factor in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ardeleani, G; Bragato, R; Morganti, A; Pulzzani, E; Sala, C; Zanchetti, A	1
Azizi, M; Guyene, TT; Mangold, B; Massien, C; Ménard, J; Vesterqvist, O	1
Burnett , JC; Chen, HH; Harty, GJ; Lainchbury, JG; Matsuda, Y	1
Azizi, M; Bissery, A; Guyene, TT; Labatide-Alanore, A; Lamarre-Cliche, M; Ménard, J	1
Maniu, CV; Meyer, DM; Redfield, MM	1
Bayerle-Eder, M; Gasic, S; Kreiner, G; Nowotny, P; Pleiner, H; Raffesberg, W; Vierhapper, H; Waldhäusl, W; Wolzt, M; Zangeneh, M	1
Burrell, LM; Cooper, ME; Jaworski, K; Kubota, E; Mifsud, SA; Wilkinson-Berka, JL	1

Trials

2 trial(s) available for fosinopril and atrial natriuretic factor

Article	Year
Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans. Clinical pharmacology and therapeutics, 1999, Volume: 65, Issue:4 Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fosinopril; Humans; Male; Neprilysin; Pyridines; Reference Values; Renin; Thiazepines; Time Factors	1999
Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake. Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:10 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelins; Fosinopril; Humans; Male; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Protein Precursors; Pyridines; Renin; Sodium, Dietary; Thiazepines; Time Factors	2002

Article

Year

Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.

Clinical pharmacology and therapeutics, 1999, Volume: 65, Issue:4

Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Fosinopril; Humans; Male; Neprilysin; Pyridines; Reference Values; Renin; Thiazepines; Time Factors

1999

Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.

Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:10

Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelins; Fosinopril; Humans; Male; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Protein Precursors; Pyridines; Renin; Sodium, Dietary; Thiazepines; Time Factors

2002

Other Studies

5 other study(ies) available for fosinopril and atrial natriuretic factor

Article	Year
Reciprocal changes in atrial natriuretic factor and aldosterone during angiotensin converting enzyme inhibition in man. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1989, Volume: 7, Issue:6 Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Dose-Response Relationship, Drug; Fosinopril; Heart Rate; Humans; Male; Potassium; Proline; Reference Values; Renin	1989
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dogs; Fosinopril; Glomerular Filtration Rate; Heart Failure; Male; Neprilysin; Polysaccharides; Protease Inhibitors; Pyridines; Receptors, Atrial Natriuretic Factor; Sodium; Thiazepines	2001
Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertension. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:4 Topics: Adrenomedullin; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Dogs; Fosinopril; Hemodynamics; Hypertension; Kinetics; Male; Neprilysin; Peptides; Protease Inhibitors; Pyridines; Thiazepines; Vasoconstrictor Agents	2002
ANP but not BNP reflects early left diastolic dysfunction in type 1 diabetics with myocardial dysinnervation. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003, Volume: 35, Issue:5 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diastole; Female; Fosinopril; Glycated Hemoglobin; Heart; Hemodynamics; Humans; Male; Natriuretic Peptide, Brain	2003
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2004, Volume: 26, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Hypertension; Kidney; Male; Models, Cardiovascular; Neprilysin; Pyridines; Rats; Renin; Statistics as Topic; Survival Analysis; Systole; Thiazepines; Time Factors; Treatment Outcome	2004